Alzheimer's Disease can be different for everyone and researchers at UNLV want to know why.

Anti-amyloid drugs have transformed the Alzheimer’s disease (AD) treatment landscape, marking the first time clinicians have had access to disease-modifying treatments. Yet their use is limited to a relatively small subset of patients with early symptomatic disease.

The behavioral health sector is under pressure from every direction: workforce shortages, surging patient demand, reimbursement headwinds and the persistent stigma that keeps patients from seeking care. But across the country, health system leaders are finding that technology — deployed thoughtfully — may be one of the most powerful tools they have.

The Food and Drug Administration has approved a new sunscreen active ingredient for use in over-the-counter products, marking the first time in roughly 20 years that Americans will have access to a new formula.

Professional acrobats, circus performers, physicians and researchers gathered Saturday at UNLV for a conference aimed at improving medical care for performers whose jobs demand extreme strength, flexibility and endurance.

Provider shortages in any field are problematic for a myriad of reasons, the main one being access. Without access, it is extremely difficult to receive timely care. A program called BeHERENV was created to address this issue.

Research shows that a novel pill helped people with advanced pancreatic cancer live longer, raising hopes of long-needed better treatments for one of the deadliest types of cancer. The drug is called daraxonrasib and it blocks a mutated protein that fuels tumor growth in more than 90% of pancreatic cancer cases — a target that had eluded treatment for decades.

Southern Nevada is seeing its first reported case of West Nile virus this season, with Clark County confirming an infection in a local resident.

Study comes amid growing calls to end the seasonal practice of changing clocks in the U.S.

Scott McDonald and Dr. Nathan Hollister — co-founders of Circus Meets Medicine and UNLV Consortium of Arts + Medicine — joined us with the details on their Circus Meets Medicine Medical Conference.

Results from a late-stage clinical trial of the pill daraxonrasib offer new hope for a notoriously deadly disease, doctors say.

Sampling sewage lines directly serving healthcare facilities allows scientists to identify drug-resistant fungus strains of candida auris (C. auris) five months before patient symptoms emerge.